Nascent Biotech Inc.: Nascent Biotech Receives $750k Milesto

Milestone Payment is the Second of Four in $5M Pritumumab Licensing DealVERO BEACH, FL / ACCESSWIRE / February 23, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company")

Related Keywords

United States , America , Kostenloser Wertpapierhandel , Sean Carrick , Exchange Commission , Bioray Pharmaceutical Ltd , Nascent Biotech Inc , Securities Exchange , Nascent Biotech Inc Form , Milestone Payment , Pritumumab Licensing , Nascent Biotech , Bioray Pharmaceutical , Licensing Agreement , Second Payment , North America , Securities Act , Securities Exchange Act , Private Litigation Reform Act , Nascent , Biotech , Eceives , 650k , Milestone , Payment , Rom , Bioray , Harmaceutical ,